New analogues of rosaramicin isolated from a Micromonospora strain. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties.
K Funaishi, K Kawamura, F Satoh, M Hiramatsu, M Hagiwara, M Okanish
Index: J. Antibiot. 43(8) , 938-47, (1990)
Full Text: HTML
Abstract
Antibiotics 6108 A1, B, C and D, a new series of analogues of rosaramicin, were found together with rosaramicin, juvenimicin A4 and M-4365 A1 from the cultured broth of strain BA06108 which was assigned to be a new species of Micromonospora. 6108 A1 and C showed inhibitory activity against Gram-positive and some Gram-negative bacteria as potent as rosaramicin and exhibited low acute toxicity in mice. However, 6108 B showed less potent antimicrobial activity and 6108 D showed higher toxicity than those two antibiotics.
Related Compounds
Related Articles:
A new Micromonospora-produced macrolide antibiotic, rosamicin.
1972-11-01
[J. Antibiot. 25 , 641, (1972)]
2013-03-01
[Antimicrob. Agents Chemother. 57(3) , 1529-31, (2013)]
1992-01-01
[J. Bacteriol. 174(1) , 161-5, (1992)]
2007-04-11
[J. Pharm. Biomed. Anal. 43(5) , 1628-37, (2007)]
Repromicin derivatives with potent antibacterial activity against Pasteurella multocida.
1997-03-14
[J. Med. Chem. 40(6) , 1041-5, (1997)]